Menu Search
Equities

Chr Hansen Holding A/S

CRTSF:PKL

Chr Hansen Holding A/S

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)76.94
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change+2.25%
  • Beta--
Data delayed at least 15 minutes, as of May 09 2023.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Chr Hansen Holding A/S is a Denmark-based bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The Company’s business is divided into three divisions, namely Food Cultures & Enzymes, Health & Nutrition and Natural Colors. The Food Cultures & Enzymes division develops and produces cultures, enzymes and probiotics for the food industry in general and the dairy industry in particular. The Health & Nutrition division develops, produces and sells products for the dietary supplement, over-the-counter pharmaceutical, infant formula and animal feed industries. The Natural Colors division develops and supplies natural color solutions to the food and beverage industry, in particular the beverage, confectionery, ice cream, dairy, fruit preparation and prepared food segments. The Company operates in Europe, North and South America, as well as Asia Pacific, Middle East and Africa.

  • Revenue in DKK (TTM)9.63bn
  • Net income in DKK1.70bn
  • Incorporated2004
  • Employees3.69k
  • Location
    Chr Hansen Holding A/SBoege Alle 10-12HOERSHOLM 2970DenmarkDNK
  • Phone+45 45747474
  • Fax+45 45748888
  • Websitehttps://www.chr-hansen.com/
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.